Opthea Ltd
Opthea Limited, a clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States. Its development activities are based on the intellectual property portfolio covering vascular endothelial growth factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well… Read more
Opthea Ltd (OPT) - Total Assets
Latest total assets as of December 2024: $145.77 Million USD
Based on the latest financial reports, Opthea Ltd (OPT) holds total assets worth $145.77 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Opthea Ltd - Total Assets Trend (1989–2024)
This chart illustrates how Opthea Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Opthea Ltd - Asset Composition Analysis
Current Asset Composition (June 2024)
Opthea Ltd's total assets of $145.77 Million consist of 99.7% current assets and 0.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 91.4% |
| Accounts Receivable | $11.82 Million | 6.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1989–2024)
This chart illustrates how Opthea Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Opthea Ltd's current assets represent 99.7% of total assets in 2024, an increase from 56.3% in 1989.
- Cash Position: Cash and equivalents constituted 91.4% of total assets in 2024, up from 1.1% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 1989.
- Asset Diversification: The largest asset category is accounts receivable at 6.3% of total assets.
Opthea Ltd Competitors by Total Assets
Key competitors of Opthea Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Opthea Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Opthea Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Opthea Ltd is currently not profitable relative to its asset base.
Opthea Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.57 | 5.10 | 12.46 |
| Quick Ratio | 1.57 | 5.15 | 12.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $52.38 Million | $ 133.75 Million | $ 73.14 Million |
Opthea Ltd - Advanced Valuation Insights
This section examines the relationship between Opthea Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.31 |
| Latest Market Cap to Assets Ratio | 2.78 |
| Asset Growth Rate (YoY) | 27.4% |
| Total Assets | $188.79 Million |
| Market Capitalization | $524.82 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Opthea Ltd's assets at a significant premium ( 2.78x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Opthea Ltd's assets grew by 27.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Opthea Ltd (1989–2024)
The table below shows the annual total assets of Opthea Ltd from 1989 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | $188.79 Million | +27.40% |
| 2023-06-30 | $148.19 Million | +69.70% |
| 2022-06-30 | $87.32 Million | -52.64% |
| 2021-06-30 | $184.36 Million | +156.46% |
| 2020-06-30 | $71.89 Million | +90.88% |
| 2019-06-30 | $37.66 Million | -18.26% |
| 2018-06-30 | $46.08 Million | -18.51% |
| 2017-06-30 | $56.54 Million | +231.59% |
| 2016-06-30 | $17.05 Million | -7.64% |
| 2015-06-30 | $18.46 Million | +57.38% |
| 2014-06-30 | $11.73 Million | -21.67% |
| 2013-06-30 | $14.98 Million | -35.26% |
| 2012-06-30 | $23.13 Million | -11.66% |
| 2011-06-30 | $26.19 Million | -11.12% |
| 2010-06-30 | $29.46 Million | -11.56% |
| 2009-06-30 | $33.31 Million | -35.34% |
| 2008-06-30 | $51.52 Million | -9.14% |
| 2007-06-30 | $56.71 Million | +29.51% |
| 2006-06-30 | $43.79 Million | +33.02% |
| 2005-06-30 | $32.92 Million | +11.72% |
| 2004-06-30 | $29.46 Million | +18.65% |
| 2003-06-30 | $24.83 Million | +5.73% |
| 2002-06-30 | $23.49 Million | -3.61% |
| 2001-06-30 | $24.37 Million | +60.12% |
| 2000-06-30 | $15.22 Million | +108.51% |
| 1999-06-30 | $7.30 Million | +62.50% |
| 1998-06-30 | $4.49 Million | -18.21% |
| 1997-06-30 | $5.49 Million | +39.73% |
| 1996-06-30 | $3.93 Million | +83.40% |
| 1995-06-30 | $2.14 Million | +0.80% |
| 1994-06-30 | $2.13 Million | +29.83% |
| 1993-06-30 | $1.64 Million | -1.89% |
| 1992-06-30 | $1.67 Million | +26.22% |
| 1991-06-30 | $1.32 Million | -13.64% |
| 1990-06-30 | $1.53 Million | -37.40% |
| 1989-06-30 | $2.45 Million | -- |